Business
What Goldman Sachs is saying about the CSL (ASX:CSL) share price after its R&D update
Image source: Getty Images
Last week was a reasonably disappointing one for the CSL Limited (ASX: CSL) share price.
Despite releasing its research and development (R&D) update for 2021, the biotherapeutics company’s shares ended the period with a weekly decline of 0.5%.
What was the reaction…
Continue Reading
-
Business21 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Business21 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News21 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Noosa News21 hours agoDid AI write your accounting expert’s report? – Proctor